Andrew D Sklawer - Net Worth and Insider Trading
Andrew D Sklawer Net Worth
The estimated net worth of Andrew D Sklawer is at least $2,547 dollars as of 2024-06-10. Andrew D Sklawer is the COO and Secretary of Fresh Tracks Therapeutics Inc and owns about 2,769 shares of Fresh Tracks Therapeutics Inc (FRTX) stock worth over $2,547. Details can be seen in Andrew D Sklawer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andrew D Sklawer has not made any transactions after 2021-05-17 and currently still holds the listed stock(s).
Transaction Summary of Andrew D Sklawer
Andrew D Sklawer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew D Sklawer owns 1 companies in total, including Fresh Tracks Therapeutics Inc (FRTX) .
Click here to see the complete history of Andrew D Sklawer’s form 4 insider trades.
Insider Ownership Summary of Andrew D Sklawer
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
FRTX | Fresh Tracks Therapeutics Inc | 2021-06-14 | COO and Secretary |
Andrew D Sklawer Latest Holdings Summary
Andrew D Sklawer currently owns a total of 1 stock. Andrew D Sklawer owns 2,769 shares of Fresh Tracks Therapeutics Inc (FRTX) as of May 17, 2021, with a value of $2,547.
Latest Holdings of Andrew D Sklawer
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
FRTX | Fresh Tracks Therapeutics Inc | 2021-05-17 | 2,769 | 0.92 | 2,547 |
Holding Weightings of Andrew D Sklawer
Andrew D Sklawer Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew D Sklawer has made a total of 1 transactions in Fresh Tracks Therapeutics Inc (FRTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fresh Tracks Therapeutics Inc is the acquisition of 342 shares on May 17, 2021, which cost Andrew D Sklawer around $12,300.
Insider Trading History of Andrew D Sklawer
- 1
Andrew D Sklawer Trading Performance
GuruFocus tracks the stock performance after each of Andrew D Sklawer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew D Sklawer is -22.96%. GuruFocus also compares Andrew D Sklawer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew D Sklawer within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew D Sklawer's insider trading performs compared to the benchmark.
Performance of Andrew D Sklawer
Andrew D Sklawer Ownership Network
Ownership Network List of Andrew D Sklawer
Ownership Network Relation of Andrew D Sklawer
Andrew D Sklawer Owned Company Details
What does Fresh Tracks Therapeutics Inc do?
Who are the key executives at Fresh Tracks Therapeutics Inc?
Andrew D Sklawer is the COO and Secretary of Fresh Tracks Therapeutics Inc. Other key executives at Fresh Tracks Therapeutics Inc include Chief Medical Officer Monica E. Luchi , director & CHAIRMAN OF THE BOARD Reginald L Hardy , and General Counsel and CCO David R. Mcavoy .
Fresh Tracks Therapeutics Inc (FRTX) Insider Trades Summary
Over the past 18 months, Andrew D Sklawer made no insider transaction in Fresh Tracks Therapeutics Inc (FRTX). Other recent insider transactions involving Fresh Tracks Therapeutics Inc (FRTX) include a net sale of 110 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Fresh Tracks Therapeutics Inc (FRTX) in total and bought 386,399 shares, with a net purchase of 386,399 shares. During the past 18 months, 110 shares of Fresh Tracks Therapeutics Inc (FRTX) were sold and 680,912 shares were bought by its insiders, resulting in a net purchase of 680,802 shares.
Fresh Tracks Therapeutics Inc (FRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fresh Tracks Therapeutics Inc Insider Transactions
Andrew D Sklawer Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew D Sklawer. You might contact Andrew D Sklawer via mailing address: 5777 Central Avenue, Suite 102, Boulder Co 80301.